Incannex Development Update for IHL-42X for Obstructive Sleep Apnoea (‘OSA’)
17 nov. 2022 08h00 HE
|
Incannex Healthcare
Highlights: Incannex has engaged CMAX Clinical Research and Novotech CRO to undertake a bioavailability/bioequivalence (‘BA/BE’) study to assess the pharmacokinetics and tolerability of IHL-42X in...
Incannex Healthcare Quarterly Activities Report and Appendix 4C Cash Flow Statement
28 oct. 2022 08h00 HE
|
Incannex Healthcare
MELBOURNE, Australia, Oct. 28, 2022 (GLOBE NEWSWIRE) -- Clinical stage pharmaceutical development company, Incannex Healthcare Limited (ASX: IHL) (NASDAQ: IXHL), (‘Incannex’ or the ‘Company’), is...
Incannex Completes Dosing in Phase 1 Clinical Trial to Assess Multi-Use, Anti-Inflammatory Drug IHL-675A; Proceeds to Phase 2 Clinical Trials
13 oct. 2022 08h00 HE
|
Incannex Healthcare
Highlights: Patient dosing has been completed in the Phase 1 clinical trial measuring the safety, tolerability, and pharmacokinetic profiles of IHL-675AIHL-675A has been well tolerated, with no...
Incannex Completes Positive Pre-IND Meeting with US FDA on IHL-216A for Treatment of Concussion and Traumatic Brain Injury
11 oct. 2022 08h00 HE
|
Incannex Healthcare
MELBOURNE, Australia, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL) (‘Incannex’ or the ‘Company’), a clinical-stage pharmaceutical company developing unique...
Incannex to Participate in the Prestigious H.C. Wainwright 24th Annual Global Investment Conference
08 sept. 2022 09h15 HE
|
Incannex Healthcare
MELBOURNE, Australia, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL), (‘Incannex’ or the ‘Company’) a pharmaceutical company developing medicinal...
Incannex Appoints FDA Regulatory Affairs Expert Mr Robert B. Clark to the Board of Directors
17 août 2022 08h00 HE
|
Incannex Healthcare
Highlights: Highly experienced pharmaceutical executive with 20+ years at Pfizer and 10+ years at Novo NordiskSecured FDA registration and marketing approval for 12 significant new drugs in the past...